Back
Atara Biotherapeutics, Inc. 10K Form
Sell
37
ATRA
Atara Biotherapeutics, Inc.
Last Price:
$14.47
Seasonality Move:
-2.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATRA News And Ratings
See the #1 stock for the next 7 days that we like better than ATRA
ATRA Financial Statistics
Sales & Book Value
| Annual Sales: | $128.9M |
|---|---|
| Cash Flow: | $-9.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-5.08 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 2.19220 |
|---|---|
| Net Income (TTM): | $23.4M |
| Gross Margin: | $107.9M |
| Return on Equity: | -2818.48% |
| Return on Assets: | 30.72% |
Atara Biotherapeutics, Inc. Earnings Forecast
Key Atara Biotherapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for ATRA is 83.71%.
-
The Selling, General & Administrative Expenses for ATRA have been equal to 30.93% of Gross Profit Margin.
-
The Research & Development expenses have been 114.57% of Revenue.
-
The Net Earning history of ATRA is -66.23% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 7 years.
Atara Biotherapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATRA |
| CUSIP: | 046513 |
| Website: | atarabio.com |
Debt
| Debt-to-Equity Ratio: | -1.6 |
|---|---|
| Current Ratio: | 1.02 |
| Quick Ratio: | 0.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 31.73 |
ATRA Technical Analysis vs Fundamental Analysis
Sell
37
Atara Biotherapeutics, Inc. (ATRA)
is a Sell
Is Atara Biotherapeutics, Inc. a Buy or a Sell?
-
Atara Biotherapeutics, Inc. stock is rated a SellThe current Atara Biotherapeutics, Inc. [ATRA] share price is $14.20. The Score for ATRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.